Daily Maverick

DM is much better if you are signed in...

Enter your email below and we will send you a mail with a link or one-time pin to login

Sign in with OAuth

Get Support DM Shop Support DM

Gilead

How South Africa can help secure immediate, global access to HIV prevention drug lenacapavir

Op-eds

How South Africa can help secure immediate, global access to HIV prevention drug lenacapavir

By Tian Johnson, Fatima Hassan, Asia Russell and Sangeeta Shashikant

Talks have started to get the twice-yearly anti-HIV jab registered in SA

Maverick Citizen

Talks have started to get the twice-yearly anti-HIV jab registered in SA

By Mia Malan

Lenacapavir — what it would it take to get the six-monthly anti-HIV jab to South Africa

Maverick Citizen

Lenacapavir — what it would it take to get the six-monthly anti-HIV jab to South Africa

By Mia Malan and Linda Pretorius

Gilead questions WHO study that cast doubts on drug's COVID-19 benefits

World

Gilead questions WHO study that cast doubts on drug's COVID-19 benefits

By Reuters

A redeeming moment for the SA government: A case for compulsory licensing in the age of Covid-19

South Africa

A redeeming moment for the SA government: A case for compulsory licensing in the age of Covid-19

By Fatima Hassan

Return to Gilead – even more gripping this time around

Maverick Life

Return to Gilead – even more gripping this time around

By Ed Stoddard